Cargando…

Prescribing antipsychotic medication for adults with intellectual disability: shared responsibilities between mental health services and primary care

AIMS AND METHOD: We conducted a secondary analysis of data from a Prescribing Observatory for Mental Health audit to assess the quality of requests from intellectual disability services to primary care for repeat prescriptions of antipsychotic medication. RESULTS: Forty-six National Health Service T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paton, Carol, Roy, Ashok, Purandare, Kiran, Rendora, Olivia, Barnes, Thomas R. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813760/ https://www.ncbi.nlm.nih.gov/pubmed/34308827 http://dx.doi.org/10.1192/bjb.2021.72

Ejemplares similares

Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice
por: Paton, Carol, et al.
Publicado: (2016)

Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit
por: Paton, Carol, et al.
Publicado: (2022)

Intellectual disability and antipsychotics
por: Iñiguez, I. Cuevas, et al.
Publicado: (2021)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers
por: de Kuijper, Gerda, et al.
Publicado: (2022)

Management of medically assisted withdrawal from alcohol in acute adult mental health and specialist addictions in-patient services: UK clinical audit findings
por: Sinclair, Julia, et al.
Publicado: (2023)

COVID-19-related prescribing challenge in intellectual disability
por: Rauf, Bushra, et al.
Publicado: (2021)

UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020)

Side-effect monitoring of continuing LAI antipsychotic medication in UK adult mental health services
por: Paton, Carol, et al.
Publicado: (2021)

Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018)

A Snapshot of Prescribing in Intellectual Disability CAMHS
por: Simpson, Struan
Publicado: (2022)

Audit on antipsychotic prescribing in children and young people with a learning disability under the care of mental health services in Surrey
por: James, Timothy Cherian, et al.
Publicado: (2021)

The phenomenology of mental imagery in people with intellectual disabilities
por: Hewitt, Olivia Mary, et al.
Publicado: (2022)

Psychotropic prescribing practices in adults with intellectual disability and autism spectrum disorder in Richmond Neurodevelpmental Services
por: Dissanayake, Anushka, et al.
Publicado: (2021)

Undertaking clinical audit, with reference to a Prescribing Observatory for Mental Health audit of lithium monitoring
por: Paton, Carol, et al.
Publicado: (2014)

What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication
por: Wykes, T., et al.
Publicado: (2017)

How Should Community Mental Health of Intellectual Disability Services Evolve?
por: Hemmings, Colin, et al.
Publicado: (2014)

European service perspectives for people with intellectual disabilities and mental health problems
por: Holt, Geraldine, et al.
Publicado: (2008)

Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services
por: Paton, Carol, et al.
Publicado: (2020)

Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022)

Evaluation of Serum Prolactin Levels in Intellectually Disabled Patients Using Antipsychotic Medications
por: Lambert, Tammy L, et al.
Publicado: (2012)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

Primary Care: Mental and Behavioral Health and Persons with Intellectual and Developmental Disabilities
por: Ervin, David A., et al.
Publicado: (2014)

Primary care for people with an intellectual disability — what is prescribed? An analysis of medication recommendations from the BEACH dataset
por: Salomon, Carmela, et al.
Publicado: (2018)

Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs
por: Vigod, Simone N., et al.
Publicado: (2016)

Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
por: Lunsky, Yona, et al.
Publicado: (2017)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience
por: de Kuijper, Gerda, et al.
Publicado: (2022)

The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services
por: Barnes, Thomas R. E., et al.
Publicado: (2020)

Antipsychotic prescribing in dementia
por: McLoughlin, James, et al.
Publicado: (2021)

COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021)

De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary
por: Flood, Bernadette
Publicado: (2018)

Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
por: Sheehan, Rory, et al.
Publicado: (2015)

Clinical audit of cardio-metabolic monitoring in people with intellectual disability (PWID) taking antipsychotic medication
por: Kyaw, Sandar, et al.
Publicado: (2021)

Re-Audit of Prescribing Responsibility for Antipsychotic Depots for Shared Care Patients(PRAD-SCP)
por: Ziriki, Ayebakari, et al.
Publicado: (2023)

Conversations about health—Sharing the personal experiences of women with intellectual disabilities
por: Cytowska, Beata, et al.
Publicado: (2020)

Services for people with intellectual disabilities and mental health problems in Singapore: perspectives from mainstream mental health professionals
por: Ee, Jonathan, et al.
Publicado: (2021)

What do specialist mental health professionals think of the mental health services for people with intellectual disabilities in Singapore?
por: Ee, Jonathan, et al.
Publicado: (2021)

Mental healthcare for adults with mild intellectual disabilities: population-based database study in Dutch mental health services
por: Pouls, Katrien P. M., et al.
Publicado: (2023)

Adults with intellectual disabilities and mental health disorders in primary care: a scoping review
por: Pouls, Katrien PM, et al.
Publicado: (2021)

Primary mental healthcare for adults with mild intellectual disabilities: a Dutch database study
por: Pouls, Katrien P. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b33r1k6ahjk4l842lobvuf039g